The expression of ALAS2, HMBS, and FXN involved in iron utilization was associated with improved OS in ovarian cancer, whereas the expression of ALAD, ALAS1, and CPOX in this process was associated with poor OS in ovarian cancer (Table 3). This evidence concerns the gene FXN and ovarian carcinoma.